Loading Events

Tuesday, April 9, 2019 | 3:00 – 7:00 p.m. ET

NC Biotechnology Center
Hamner Conference Center
15 TW Alexander Drive
Research Triangle Park, NC

Featuring a keynote session followed by a panel discussion, the forum will explore how emerging biomedical research anticipates an era of personalized medicine that can improve patient outcomes and maximize value in health care. It will also examine the public policies and medical practices that are required to keep pace with these developments.

Following the forum, we invite you to join us in the galleria for cocktails and hors d’oeuvres.


3:00 p.m. Registration

3:30 p.m. Opening Remarks

SARA IMHOF, PH.D., Senior Director, Precision Health, North Carolina Biotechnology Center

EDWARD ABRAHAMS, PH.D., President, Personalized Medicine Coalition

3:40 p.m. Keynote Addresses: Research in Personalized Medicine


INTRODUCER & MODERATOR | GEOFFREY GINSBURG, M.D., PH.D., Director, Duke University Center for Applied Genomics and Precision Medicine

STEPHANIE DEVANEY, PH.D., Deputy Director, All of Us Research Program, U.S. National Institutes of Health

CATALINA LOPEZ-CORREA, M.D., PH.D., Chief Scientific Officer, Vice President, Sectors, Genome British Columbia; Co-Chair, Global Genomic Medicine Collaborative

4:30 p.m. Panel Discussion: Clinical Adoption of Personalized Medicine

INTRODUCER & MODERATOR | RALPH SNYDERMAN, M.D., Chancellor Emeritus, Duke University

GABRIELA LAVEZZARI, PH.D., M.B.A., Senior Director, U.S. R & D Policy and Scientific Affairs, GlaxoSmithKline

JANET MCCAULEY, M.D., M.H.C., Senior Medical Director, Clinical Effectiveness, Blue Cross Blue Shield Association of North Carolina

JAI PATEL, PHARM.D., Chief of Pharmacology Research, Associate Professor, Division of Hematology/Oncology, Atrium Health

SHELBY D. REED, R.PH., PH.D., Past President, International Society for Pharmaco-economics and Outcomes Research (ISPOR); Professor, Population Health Sciences and Medicine, Duke University

5:30 p.m. Cocktail Reception